subject area of
- A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients Academic Article
- Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI Academic Article
- COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine Academic Article
- Characterization of structure and mechanism of transfection-active peptide–DNA complexes Academic Article
- Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo Academic Article
- Combined action of inhibitors of polyamine biosynthetic pathway with a known antimalarial drug chloroquine on plasmodium falciparum Academic Article
- Effects of Chloroquine on Patients with Cutaneous Porphyria of the "Symptomatic" Type Academic Article
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Academic Article
- Interventions for cutaneous disease in systemic lupus erythematosus Academic Article
- Massive infection with fasciola hepatica in man Academic Article
- Multifactorial Regulation of Prostaglandin Synthesis in Preovulatory Goldfish Ovarian Follicles1 Academic Article
- PSYCHOTIC SYMPTOMS IN VOLUNTEERS SERVING OVERSEAS Academic Article
- Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases Academic Article
- Porphyria cutanea tarda: clinical and laboratory features. Academic Article
- Problems of Antiarthritic Therapy in the Elderly Academic Article
- Processing fate of protein antigen attached to IgD or MHC molecules on normal B lymphocytes using heterocrosslinked bispecific antibodies Academic Article
- Real-Time PCR Assay for Rapid Detection and Analysis of PfCRT Haplotypes of Chloroquine-Resistant Plasmodium falciparum Isolates from India Academic Article
- Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) Academic Article
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases Academic Article
- Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article
- Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians Academic Article